Search research articles
Contact Us
Filters
Showing results (331-340 of 664) with videos related to
Page
of 67
Sort By:
World Journal of Urology
|
January 22, 2004
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management
Anna C Pfannenberg, Karin Oechsle, Carsten Bokemeyer, et al.
European Urology
|
August 23, 2015
Guidelines on Testicular Cancer: 2015 Update
Peter Albers, Walter Albrecht, Ferran Algaba, et al.
Frontiers in Medicine
|
November 25, 2021
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
Franziska Brauneck, Pauline Weimer, Julian Schulze Zur Wiesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2009
Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma
Djordje Atanackovic, Tim Luetkens, York Hildebrandt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 9, 2010
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome
Matthias Choschzick, Paula Lassen, Annette Lebeau, et al.
European Urology
|
April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature
Fabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Oral Oncology
|
June 15, 2012
Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target
Till Sebastian Clauditz, Artur Gontarewicz, Patrick Lebok, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
Franziska Brauneck, Elisa Seubert, Jasmin Wellbrock, et al.
Journal of Cancer Survivorship : Research and Practice
|
November 4, 2021
Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study
Peter Esser, Leon Sautier, Susanne Sarkar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2010
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion
Eckart Laack, Ronald Simon, Marc Regier, et al.
Page
of 67
Search research articles
Search
Showing results (331-340 of 664) with videos related to
Sort By:
Page
of 67
World Journal of Urology
|
January 22, 2004
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management
Anna C Pfannenberg, Karin Oechsle, Carsten Bokemeyer, et al.
European Urology
|
August 23, 2015
Guidelines on Testicular Cancer: 2015 Update
Peter Albers, Walter Albrecht, Ferran Algaba, et al.
Frontiers in Medicine
|
November 25, 2021
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
Franziska Brauneck, Pauline Weimer, Julian Schulze Zur Wiesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2009
Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma
Djordje Atanackovic, Tim Luetkens, York Hildebrandt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 9, 2010
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome
Matthias Choschzick, Paula Lassen, Annette Lebeau, et al.
European Urology
|
April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature
Fabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Oral Oncology
|
June 15, 2012
Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target
Till Sebastian Clauditz, Artur Gontarewicz, Patrick Lebok, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
Franziska Brauneck, Elisa Seubert, Jasmin Wellbrock, et al.
Journal of Cancer Survivorship : Research and Practice
|
November 4, 2021
Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study
Peter Esser, Leon Sautier, Susanne Sarkar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2010
Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion
Eckart Laack, Ronald Simon, Marc Regier, et al.
Page
of 67